Lung lesions often appear in patients with sarcoidosis; however, miliary opacities are rare. We herein report the case of a 40-year-old woman with pulmonary sarcoidosis who presented with dyspnea on exertion. Subsequent computed tomography showed miliary opacities, and the presence of granulomas was confirmed by a transbronchial lung biopsy. Glucocorticoid therapy was initiated and the symptoms and miliary opacities rapidly improved. Although miliary sarcoidosis is uncommon, physicians should consider sarcoidosis in addition to tuberculosis, malignancy, and pneumoconiosis when presented with miliary opacities.
Introduction
Sarcoidosis is a disease of unknown etiology that results in the formation of granulomas in any organ. Lung lesions are a common feature of sarcoidosis, typically presenting as nodules along the bronchi, vessels, and subpleural regions; interlobular septal thickening; and bilateral perihilar opacities. However, miliary opacities are rare, and few case reports currently exist in the literature (1) .
On presentation with miliary opacities of the lung, the differential diagnosis is generally of tuberculosis, metastatic lung tumor, or pneumoconiosis. Because sarcoidosis can present in this manner and is curable with simple glucocorticoid therapy, sarcoidosis must be excluded.
We herein report the case of a woman with miliary sarcoidosis whose signs and symptoms completely resolved following glucocorticoid therapy. Furthermore, the disease did not recur six months after the end of therapy, despite the extensive lung involvement at the diagnosis.
Case Report
A 40-year-old housewife with no notable previous illnesses presented to our hospital with a 6-month history of exertional dyspnea. She had quit smoking at 38 years of age and had not consumed any medicines or supplements. She had not changed her residential location in recent years, and her living environment had not changed. Auscultation revealed no rales in either lung field, and the patient had a regular heart rhythm and no heart murmurs. At presentation, the respiratory function test revealed a vital capacity (VC) of 2.43 L, %VC of 83.6%, forced expiratory volume in one second (FEV1) of 2.06 L, FEV1% of 88.0%, and a diffusing capacity of the lung for carbon monoxide/predicted value of 48.8%. According to these results, a diminished diffusing capacity was indicated, but not a restrictive or obstructive ventilatory impairment.
Further investigation was therefore performed. The patient's laboratory findings at presentation showed normal total white blood cell (WBC) and C-reactive protein (CRP) levels. In addition, most of the lung cancer markers were normal. However, the levels of both sialyl Lewis x -i antigen and angiotensin-converting enzyme (ACE) were increased at 67 U/mL and 39.8 U/L, respectively (Table 1) . Chest radiography showed miliary nodules, and computed tomography (CT) confirmed diffuse fine pulmonary nodules with bilateral swelling of the hilar and mediastinal lymph nodes (Fig. 1) . These nodules were not prominent in the perilymphatic distribution, such as in the bronchovascular bundle and interlobular septa. Although these nodules were diffuse, they demonstrated an upper and middle lung zone predominance. Subsequent 18 F-fluorodeoxyglucose-positron emission tomography showed strong hypermetabolism in the pulmonary involvement. We then performed diagnostic bronchoscopy. The bronchoalveolar lavage (BAL) fluid of the right middle lobe showed lymphocytosis (90.5%) and an elevated CD4/8 ratio of 7.3. A transbronchial lung biopsy at the right S 8 revealed non-caseating epithelioid cell granulomas (Fig. 2) , and neither tuberculosis nor malignancy was identified. Thus, we diagnosed the patient with sarcoidosis.
During the diagnostic process, the patient developed blurred vision due to ocular sarcoidosis. According to her body weight of 61 kg, we initiated glucocorticoid therapy with prednisolone at 30 mg/day, which was approximately equal to 0.5 mg/kg. The blurred vision began to improve 1 week later. After 1 month of treatment, both the exertional dyspnea and blurred vision had resolved and the miliary nodules on chest radiography had disappeared. The miliary opacities had disappeared completely on a repeat CT at 4 months following treatment (Fig. 3) . We gradually tapered the glucocorticoid dose and her treatment was discontinued 
Discussion
Sarcoidosis is a disease of unknown etiology characterized by non-caseating granulomas. The first case report of sarcoidosis was by the English physician Jonathon Hutchinson in 1877 (2). Sarcoidosis occurs worldwide and can involve any organ. Although bilateral hilar lymphadenopathy and lung field abnormalities are common, sarcoidosis in the Japanese population tends to present with higher rates of ocular and cardiac involvement than in the Western population. These features are also reflected in the difference in the mortality rates, with pulmonary sarcoidosis the leading cause of death in Western countries and cardiac lesions in Japan (3). The incidence of sarcoidosis among Asians, including the Japanese population, is lower than that in Caucasian and Black populations (4) .
In pulmonary sarcoidosis, the typical findings include perilymphatic nodules, interlobular septal thickening, and bilateral perihilar opacities. These parenchymal abnormalities are predominant in the upper and middle lung fields. In contrast, miliary opacities are rare and atypical (1) . To the best of our knowledge, only six cases of miliary pulmonary sarcoidosis have been published in the English literature (5-10). Although the peak incidence of sarcoidosis tends to be in the third and fourth decades of life (4, 11, 12) , four of the previous reports of miliary disease were in patients in their fifth decade. Nevertheless, a single case of a 15-year-old with hypercalcemia and miliary sarcoidosis did not show any anomalous clinical features other than age. Because the present patient was also 40 years of age, it may be that the peak incidence of miliary sarcoidosis is higher than that for typical sarcoidosis. Five of the six previously reported cases were men. Furthermore, despite the evidence of miliary opacities and the confirmation of granuloma formation, three of the cases were respiratory asymptomatic. Moreover, glucocorticoid therapy was used in all cases, and only one case had any recurrence. In the case that had recurrent disease, sustained remission was obtained after a second course of glucocorticoid therapy (Table 2) . Thus, according to the data from the previous case reports, miliary sarcoidosis may tend to present in middle-aged patients, have a male preponderance, and have a milder disease course. Further case reports are necessary to confirm these findings.
The typical differential diagnosis for miliary opacities of the lung includes tuberculosis, metastatic lesions, and pneumoconiosis. Of these, tuberculosis and metastatic lesions are hematogenous and tend to be randomly distributed, whereas pneumoconiosis tends to present in the centrolobular and bronchovascular bundles as in sarcoidosis. Therefore, important diagnostic considerations include the following: any history of fever or sputum production, the duration and progression of the symptoms, a past history of malignancy, smoking status, occupational history, the physical examination and laboratory findings (including blood tests and a bacteriological examination), and pathological examinations. Careful attention is therefore essential to avoid making a misdiagnosis.
Sarcoidosis is often detected on a chest radiograph during the routine screening in an asymptomatic patient (13) and has a high rate of spontaneous remission (14) . Therefore, in an asymptomatic patient, it may be unnecessary to treat the lung lesions. In the present patient, we administered glucocorticoid therapy because she had dyspnea on exertion; the decision to treat was vindicated by the prompt resolution of the symptoms and miliary opacities shortly after the treatment was initiated.
We are confident that sarcoidosis was correctly diagnosed in the present case. This is supported by the elevated serum ACE level, the high CD4/CD8 ratio in the BAL fluid, the presence of non-caseating epithelioid cell granulomas in the lung tissue, and the response to glucocorticoid therapy. Furthermore, the CRP level is generally elevated in up to 85% patients with tuberculosis (15), but it was normal in the pre- sent patient. Moreover, neither tuberculosis nor malignancy was detected in the BAL fluid or lung tissue, no malignant tumors appeared during the follow-up, and the patient denied any occupational exposure suggestive of pneumoconiosis, including silicosis, asbestosis, aluminum lung, and welder's lung. Taken together, these findings suggested that the patient's disease was highly likely to be miliary sarcoidosis. The reason that sarcoidosis rarely exhibits miliary opacities is not clear. For instance, miliary opacities may occur when granulomas uniformly appear around the peripheral bronchus. The miliary opacities in the present case demonstrated upper and middle lung zone predominance, which is typical in sarcoidosis. In miliary sarcoidosis, a perilymphatic distribution and upper and middle lung zone predominance, demonstrating relatively mild lung involvements, are typically observed. The interstitial pulmonary tissue in the present case was estimated to have been widely damaged in a typical sarcoidosis-like manner according to the presence of extensive opacities. Therefore, the diminished diffusing capacity in the present case was accountable.
Although miliary sarcoidosis is rare, unlike other diseases presenting with miliary opacities, it is easily curable with simple glucocorticoid therapy. Sarcoidosis should be included in the differential diagnosis when miliary opacities are observed in the lung. Although the clinical features of miliary sarcoidosis (such as age, sex, race, and symptoms) are yet to be established due to the limited number of case reports, it is possible that there is a middle-age and male preponderance along with a relatively mild disease course. However, it is necessary to accumulate more case reports of miliary sarcoidosis to clarify our understanding of this interesting presentation.
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